The oncolytic activity of the four oncolytic adenoviruses and a combination therapy (ONCOS-207 + ONCOS-209) viral preparations were assessed against four human melanoma cell lines (A2058, A375, SK-MEL-2, and SK-MEL-28) that are negative for expression of argininosuccinate synthetase-1.43 Here, ASS1 is linked to melanoma.